PROM1 and cancer: In SPNs-treated PANC-1 cells, under-expression of miR-155, miR-21, and miR-222 in association with the decrease in CD markers CD24, CD44, and CD133 may indicate the importance of SPNs in inhibition of onco-miRs and stemness properties of PANC-1 cancer cells.